Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients.

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients.

Cytomegalovirus (CMV) infections in liver transplant recipients are common and result in significant morbidity and mortality. Intravenous ganciclovir or oral valganciclovir are the standard treatment for CMV infection. The present study investigates the efficacy of oral valganciclovir in CMV infecti...

Full description

Bibliographic Details
Main Authors: Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Young Eun Ha, Dong Hyun Sinn, Gyu-Seong Choi, Kyong Ran Peck, Suk-Koo Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4420490?pdf=render

Internet

http://europepmc.org/articles/PMC4420490?pdf=render

Similar Items